Forge Biologics
Provides contract manufacturing and development for gene therapies.
Company facts
- Founded
- 2020
- Employees
- 422
- Headquarters
- United States
- CEO
- Timothy J. Miller, Ph.D.
- Type
- Private
- Funding
- Series C · $90M · 2022
About
Forge Biologics, headquartered in Columbus, Ohio, is a leading gene therapy development engine dedicated to making life-changing gene therapies accessible for patients. The company operates as a hybrid contract development and manufacturing organization (CDMO), providing comprehensive solutions that drive the development of innovative gene therapies from the discovery stage through to delivery. By collaborating with a wide range of partners, including biotech firms, academic institutions, and patient advocates, Forge aims to streamline the process of bringing transformative medicines to market. The facilities at Forge Biologics represent a significant investment in cutting-edge technology to support the complex needs of gene therapy development. Their state-of-the-art manufacturing capabilities are designed to support the production of adeno-associated virus (AAV) vectors, a key component in many gene therapy products. Forge is committed to a patient-first approach, ensuring that their work profoundly impacts the lives of individuals suffering from severe genetic conditions. With ongoing projects and advancements such as their FUEL™ AAV manufacturing platform, Forge continues to be at the forefront of biopharmaceutical innovation, striving for excellence in every aspect of gene therapy production and development.
Open positions
Associate Director, PD Upstream
Forge Your Future with Us: At Forge Biologics, we believe in turning bold ideas into life-changing realities. Our mission is simple yet powerful: to enable access to life-changing gene therapies and help bring them…